Regulatory challenges and considerations for the clinical application of CAR T cell therapy

EXPERT OPINION ON BIOLOGICAL THERAPY(2021)

Cited 1|Views5
No score
Abstract
Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the treatment of relapsed and refractory hematologic malignancies leading to their integration into treatment algorithms. Tisagen...
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined